N/A
N=21
Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU When Using Fast Gelling Dressing as Intended.
Diabetic Foot Ulcers
Bottom Line
View on ClinicalTrials.gov: NCT02091778 ↗Enrolled (actual)
21
Serious AEs
9.5%
Results posted
Feb 2016
Primary outcome: Primary: Change in Peri-wound Skin — 8 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Fast gelling dressing (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Molnlycke Health Care AB
- Primary completion
- Mar 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Peri-wound Skin |
8 | — |
Summary
The primary objective of this post market clinical follow-up (PMCF) investigation is to evaluate performance and safety of fast gelling dressing when used as intended in Diabetic Foot Ulcer (DFU).
The primary endpoint will be Changes from baseline in the condition of the peri-wound skin measured by the following variables; maceration, redness/irritation, rash/eczema, blistering, dermatitis, skin stripping, trauma to wound edges and product degradation on the skin
Eligibility Criteria
Inclusion Criteria
- Both gender ≥18 years old.
- Subjects with type 1 or 2 diabetes mellitus.
- Texas Grade A1 or 2, C1 or 2
- Exuding diabetic foot ulcer
- Ulcer localisation; below the ankle
- Signed Informed Consent.
Exclusion Criteria
- Known allergy/hypersensitivity to the dressing.
- HbA1c ≥ 10% (86 mmol/mol) (most recent value within 3 months)
- Wound infection requiring systemic treatment
- Subjects who will have problems following the protocol.
- Subjects included in other ongoing clinical investigation at present or during the past 30 days.
- Toe pressure less than 70 mmHg
- Clinical suspicion of osteomyelitis (based on probe to bone/radiological changes)
- Dry wounds
Data sourced from ClinicalTrials.gov (NCT02091778). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.